Q3 2016 Holdings
Filed 2016-11-14 | 90 holdings | $67.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $19.4M | 4,401,846 | 28.9% |
| Axogen Inc(AXGN) | COM | 05463X106 | $17.1M | 1,893,030 | 25.4% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $14.8M | 943,433 | 22.0% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $8.0M | 618,643 | 11.9% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $3.0M | 116,000 | 4.4% |
| Acura Pharmaceuticals Inc(ACUR) | COM PAR | 00509L802 | $1.6M | 1,025,641 | 2.4% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $1.3M | 13,800 | 1.9% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $133.9K | 1,008,475 | 0.2% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $128.1K | 5,639,727 | 0.2% |
| Horizon Pharma PLC | SHS | G4617B105 | $116.7K | 6,434,439 | 0.2% |
| Nxstage Medical Inc | COM | 67072V103 | $102.4K | 4,099,175 | 0.2% |
| Avexis Inc | COM | 05366U100 | $92.2K | 2,236,701 | 0.1% |
| Horizon Pharma Invt LTD | NOTE 2.500% 3/1 | 44052TAB7 | $80.1K | $82,600,000 | 0.1% |
| Healthways Inc | NOTE 1.500% 7/0 | 422245AB6 | $79.2K | $54,382,000 | 0.1% |
| Adeptus Health Inc(ADPTEUR) | CL A | 006855100 | $68.9K | 1,600,861 | 0.1% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $63.3K | 1,743,229 | 0.1% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $57.2K | 3,435,576 | 0.1% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $56.0K | 536,355 | 0.1% |
| Mylan N V | SHS EURO | N59465109 | $54.3K | 1,423,334 | 0.1% |
| Xencor Inc(XNCR) | COM | 98401F105 | $54.1K | 2,210,900 | 0.1% |
| Array Biopharma Inc | NOTE 3.000% 6/0 | 04269XAA3 | $53.3K | $45,000,000 | 0.1% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $50.5K | 1,338,829 | 0.1% |
| Flamel Technologies SA | SPONSORED ADR | 338488109 | $50.5K | 4,072,809 | 0.1% |
| Trinity Biotech Invt LTD | NOTE 4.000% 4/0 | 89643QAB4 | $46.8K | $48,000,000 | 0.1% |
| Wright MED Group Inc | NOTE 2.000% 2/1 | 98235TAE7 | $42.8K | $40,050,000 | 0.1% |
| Aetna Inc New | COM | 00817Y108 | $42.3K | 366,000 | 0.1% |
| Endologix Inc | NOTE 2.250%12/1 | 29266SAA4 | $39.2K | $40,941,000 | 0.1% |
| AAC Hldgs Inc(AACH) | COM | 000307108 | $38.1K | 2,189,849 | 0.1% |
| Universal Amern Corp New | COM | 91338E101 | $35.1K | 4,592,060 | 0.1% |
| Nivalis Therapeutics Inc | COM | 65481J109 | $30.3K | 3,732,412 | 0.0% |
| Ehealth Inc(EHTH) | COM | 28238P109 | $29.6K | 2,640,609 | 0.0% |
| Walgreens Boots Alliance Inc(WBA) | COM | 931427108 | $28.7K | 355,957 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $28.2K | 159,500 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $27.4K | 423,112 | 0.0% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $25.1K | 1,812,778 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $25.0K | 1,403,653 | 0.0% |
| Tesaro Inc | COM | 881569107 | $24.3K | 242,300 | 0.0% |
| Davita Inc(DVA) | COM | 23918K108 | $23.1K | 350,000 | 0.0% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $23.0K | 1,709,400 | 0.0% |
| Spark Therapeutics Inc | COM | 84652J103 | $22.1K | 368,000 | 0.0% |
| Glaukos Corp(GKOS) | COM | 377322102 | $19.0K | 503,277 | 0.0% |
| Select MED Hldgs Corp(SEM) | COM | 81619Q105 | $18.3K | 1,354,662 | 0.0% |
| Invuity Inc | COM NEW | 46187J205 | $17.6K | 1,282,598 | 0.0% |
| Fluidigm Corp del | NOTE 2.750% 2/0 | 34385PAA6 | $17.0K | $27,715,000 | 0.0% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $16.3K | 311,000 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $15.2K | 224,000 | 0.0% |
| Proteon Therapeutics Inc | COM | 74371L109 | $14.7K | 1,570,467 | 0.0% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $12.1K | 1,307,058 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $11.1K | 1,650,000 | 0.0% |
| Akari Therapeutics PLC | SPONSORED ADR | 00972G108 | $9.8K | 1,150,700 | 0.0% |